ESC Professional Premium Access

Association of ticagrelor vs clopidogrel with net adverse clinical events in patients with mild thrombocytopenia undergoing PCI

Congress Presentation

About the speaker

Professor Kang-Yin Chen

2nd Hospital of Tianjin Medical University, Tianjin (China)
0 follower

5 more presentations in this session

Reduction of thrombus burden by cangrelor in ticagrelor-loaded st-elevation myocardial infarction patients with high residual platelet reactivity: the imaging sub-study of the ERMIT randomized trial

Speaker: Professor F. Beygui (Caen, FR)

Thumbnail

Disparities in the proportion of ticagrelor and prasugrel-eligible patients with NSTE-ACS in a real-world registry

Thumbnail

The safety and efficacy of indobufen or aspirin combined with clopidogrel in patients with acute myocardial infarction after percutaneous coronary intervention

Speaker: Doctor W. Dai (Tianjin, CN)

Thumbnail

Respective impact of bleeding and ischemic complications of mortality after percutaneous coronary interventions: substudy from the FRANCE-PCI registry

Speaker: Doctor P. Guedeney (Paris, FR)

Thumbnail

Complex versus non-complex, should we adjust the antiplatelet strategy to the type of percutaneous coronary intervention? Results from a real world PCI population

Speaker: Ms E. Woelders (Nijmegen, NL)

Thumbnail

Access the full session

The guardians of clotting: exploring antiplatelet strategies

Speakers: Professor K. Chen, Professor F. Beygui, Doctor W. Dai, Doctor P. Guedeney, Ms E. Woelders
Thumbnail

About the event

Image

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations